Plantar Fasciitis Management on Postural Control
Impact of Plantar Orthosis on Postural Control and Gait in Individuals With Plantar Fasciopathy
1 other identifier
interventional
24
1 country
1
Brief Summary
Foot pain is common in the general population. Plantar fasciopathy may affect 7% of the population at some time in their lives, but the incidence increases with age. This plantar problem is characterized by severe pain under the foot (at plantar level), which can be very incapacitating and disabling. This can lead to absenteeism from work, particularly for employees working in a standing posture. Various therapeutic avenues can be used to reduce pain and improve functionality, such as physiotherapy, infiltrations and surgery. In this research project, the propose the use of a conservative approach through the use of foot orthoses, which appears to be effective in reducing pain. The aim of the study is thus to better understand the effect of foot orthoses on postural balance and walking in workers with plantar fasciopathy. Participants will be assessed at baseline and eight weeks later to observe measured changes and clinical improvements following orthotic wear. Balance and gait pattern will be assessed using technological tools that have been validated in this respect. Participants will also be asked about their pain intensity. The hypothesis is that wearing the orthosis will improve the participants' balance and walking abilities, as well as reduce the level or intensity of their pain. In addition, this study could have an impact on the rate of absenteeism from work from current context of labour shortages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2023
CompletedFirst Posted
Study publicly available on registry
December 15, 2023
CompletedStudy Start
First participant enrolled
January 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2024
CompletedApril 23, 2025
April 1, 2025
12 months
November 29, 2023
April 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postural control measures
The participants will perform two 30-second trials on a strength platform (model BIOMEC400), the following tasks: without muscular vibration, with bilateral Achilles tendon vibration (Techno® concept VibrasensTM, France) in bipodal posture, and a balance task in semi-tandem posture with eyes open and closed. The vibration frequency chosen for the regions (sural triceps) will be 80 Hz. Center of Pressure (CoP) metrics will be used as main outcome such as sway CoP velocity variable (cm/s).
baseline,immediate only for experimental group), and after 8 weeks.
Gait measures
The participants will be asked to walk at normal, slow and fast speeds on a GaitRite treadmill (GAI-TRite® Platinum Plus System 16' - 4.876 m, SN: Q209, CIR Systems Inc., Franklin, NJ, USA). Participants will perform each task twice.Main gait parameters will be used as main outcomes such as velocity in m/s.
baseline,immediate only for experimental group), and after 8 weeks.
Secondary Outcomes (4)
Ankle mobility and foot position measure
baseline and after 8 weeks.
Lower Extremity Functional measure
baseline and after 8 weeks.
Pain measure by Foot function index
baseline and after 8 weeks.
Pain duration
baseline and after 8 weeks.
Study Arms (2)
Othesis intervention
EXPERIMENTALThis group with custom-made foot orthotics prescribed by podiatrists (foot impression, polypropylene orthotics and covering at podiatrists' discretion).
Control group
NO INTERVENTIONWithout orthesis prescriptions by podiatrists.
Interventions
Clinical feasibility trial with one group using a custom-made foot orthotics prescribed by podiatrists (foot impression, polypropylene orthotics and covering at podiatrists' discretion).
Eligibility Criteria
You may qualify if:
- Present a history of pain under the heels for more than 3 months
- Have a diagnosis of plantar fasciopathy
- Pain of at least 3/10 under the heel
- Have post-static dyskinesia
- To be in the job market (adults between 20 and 65 years)
You may not qualify if:
- Severe systemic diseases
- Red flags (e.g. tumors),
- Musculoskeletal deformities affecting the lower limbs
- Musculoskeletal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rubens da Silva
Saguenay, Quebec, G7H 2B1, Canada
Related Publications (13)
Duncan JR, Potter CB, Cappellini MD, Kurtz JB, Anderson MJ, Weatherall DJ. Aplastic crisis due to parvovirus infection in pyruvate kinase deficiency. Lancet. 1983 Jul 2;2(8340):14-6. doi: 10.1016/s0140-6736(83)90005-3.
PMID: 6134886BACKGROUNDBeeson P. Plantar fasciopathy: revisiting the risk factors. Foot Ankle Surg. 2014 Sep;20(3):160-5. doi: 10.1016/j.fas.2014.03.003. Epub 2014 Mar 22.
PMID: 25103701BACKGROUNDIchioka T, Tashiro T, Hara T, Ichioka E. [Trial testing of the auto-refractometer NIDEK AR-3000 for mass examination of children and kindergarten, primary, junior high, and high school students]. Josai Shika Daigaku Kiyo. 1985;14(1):139-47. No abstract available. Japanese.
PMID: 3866618BACKGROUNDRicher L, Fortin E, Gagnon G, Ngomo S, Fernandes KBP, Cortis C, Sobczak S, da Silva RA. Impact of plantar fasciitis on postural control and walking in young middle-aged adults. Foot (Edinb). 2022 Dec;53:101951. doi: 10.1016/j.foot.2022.101951. Epub 2022 Nov 4.
PMID: 36463613BACKGROUNDCrawford F, Thomson CE. WITHDRAWN. Interventions for treating plantar heel pain. Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD000416. doi: 10.1002/14651858.CD000416.pub2.
PMID: 20091508BACKGROUNDGoguel V, Rosbash M. Splice site choice and splicing efficiency are positively influenced by pre-mRNA intramolecular base pairing in yeast. Cell. 1993 Mar 26;72(6):893-901. doi: 10.1016/0092-8674(93)90578-e.
PMID: 8458083BACKGROUNDAnderson J, Stanek J. Effect of foot orthoses as treatment for plantar fasciitis or heel pain. J Sport Rehabil. 2013 May;22(2):130-6. doi: 10.1123/jsr.22.2.130. Epub 2012 Oct 2.
PMID: 23037146BACKGROUNDRedmond AC, Crosbie J, Ouvrier RA. Development and validation of a novel rating system for scoring standing foot posture: the Foot Posture Index. Clin Biomech (Bristol). 2006 Jan;21(1):89-98. doi: 10.1016/j.clinbiomech.2005.08.002. Epub 2005 Sep 21.
PMID: 16182419BACKGROUNDHouse WF, Hitselberger WE, Horn KL. The middle fossa transpetrous approach to the anterior-superior cerebellopontine angle. Am J Otol. 1986 Jan;7(1):1-4.
PMID: 3484905BACKGROUNDMok J. HIV infection in children. J R Coll Gen Pract. 1988 Aug;38(313):342-4. No abstract available.
PMID: 3076903BACKGROUNDPourtier-Piotte C, Pereira B, Soubrier M, Thomas E, Gerbaud L, Coudeyre E. French validation of the Foot Function Index (FFI). Ann Phys Rehabil Med. 2015 Oct;58(5):276-82. doi: 10.1016/j.rehab.2015.07.003. Epub 2015 Sep 4.
PMID: 26343763BACKGROUNDKadri MA, Chevalier G, Mecheri H, Ngomo S, Lavalliere M, da Silva RA, Beaulieu LD. Time course and variability of tendinous vibration-induced postural reactions in forward and backward directions. J Electromyogr Kinesiol. 2020 Apr;51:102386. doi: 10.1016/j.jelekin.2020.102386. Epub 2020 Jan 20.
PMID: 32014802BACKGROUNDHayashi K, Hirata Y, Kurushima H, Saeki M, Amioka H, Nomura S, Kuga Y, Ohkura Y, Ohtani H, Kajiyama G. Effect of dietary hydrogenated corn oil (trans-octadecenoate rich oil) on plasma and hepatic cholesterol metabolism in the hamster. Atherosclerosis. 1993 Feb;99(1):97-106. doi: 10.1016/0021-9150(93)90055-y.
PMID: 8461065BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Rubens da Silva, PhD
Université du Québec à Chicoutimi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director and professor
Study Record Dates
First Submitted
November 29, 2023
First Posted
December 15, 2023
Study Start
January 8, 2024
Primary Completion
December 28, 2024
Study Completion
December 28, 2024
Last Updated
April 23, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share